Interventi oncologici precisi in nutrizione e formazione (OnPoint) (OnPoint)
The purpose of this study is to see if survivors of breast, prostate, colorectal or lymphoma cancer who receive a personal referral to a targeted nutrition and exercise program will be able to eat a healthier diet and be more physically activity.
Panoramica dello studio
Stato
Intervento / Trattamento
- Altro: Fitbit
- Comportamentale: Nutrition and Physical Activity Prescription
- Comportamentale: Nutrition Course: Group Sessions
- Comportamentale: Physical Activity Program: Group Sessions
- Comportamentale: Nutrition Course: One on One Sessions with Registered Dietitian
- Comportamentale: Physical Activity Program: One on One Sessions with an Exercise Physiologist
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Grey Freylersythe, BS
- Numero di telefono: 305-243-9832
- Email: g.freylersythe@med.miami.edu
Backup dei contatti dello studio
- Nome: Tracy Crane, PhD, RDN
- Numero di telefono: 305-243-8255
- Email: tecrane@med.miami.edu
Luoghi di studio
-
-
Florida
-
Miami, Florida, Stati Uniti, 33136
- Reclutamento
- University of Miami
-
Contatto:
- Grey Freylersythe, BS
- Numero di telefono: (305) 243-9832
- Email: g.freylersythe@med.miami.edu
-
Contatto:
- Tracy Crane, PhD, RDN
- Numero di telefono: (305) 243-8255
- Email: tecrane@med.miami.edu
-
Investigatore principale:
- Tracy Crane, PhD, RDN
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
Inclusion Criteria - Healthcare Providers
- Provide full- or part-time care in an oncology clinical care setting at Sylvester Comprehensive Cancer Center
- Utilize the electronic medical record for patient documentation on a regular basis
- Willing to complete a 30-60-minute interview
Inclusion Criteria - Patients
- 18 years of age or older
- Any sex/gender
- Able to provide consent
- Able to read/understand English or Spanish
- Diagnosis of breast, prostate, colorectal or lymphoma cancer, 6 months post completion of primary treatment, with no evidence of primary disease
- Approval from treating oncologist, confirmed via email or in writing
- Fail to meet at least one of the American Cancer Society guidelines: engaging in >150 minutes of moderate-to-vigorous physical activity per week for the prior month or consuming at least 3 cups of vegetables and 2 cups of fruit per day over the past month.
- Internet access on a smart phone, tablet, or computer
- Agree to be randomly assigned to any study group
Exclusion Criteria:
- Less than 18 years of age
- Unable to provide consent
- Unable to read/understand English or Spanish
- Any contraindication for diet change or exercising as determined by physician
- Blank
- Engaging in >150 minutes of moderate to vigorous physical activity on average per week for the prior month
- Meeting the American Cancer Society diet recommendations (3 cups of vegetables or legumes, 2 cups of fruit, 2 serving whole grain per day, and limited red/processed meats, sugar-sweetened beverages, and highly processed foods) for the prior month
- History of dementia or major psychiatric disease which would interfere with study participation
- History of recent (≤1 yr) stroke, myocardial infarction or congestive heart failure
- Eastern Cooperative Oncology Group (ECOG) score of >2
- Severe lymphedema as determined by physician
- Receiving physical therapy treatment
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Low Complexity Group
Participants in this group will receive the low complexity intervention for up to eight (8) weeks. |
Participants will be provided with a Fitbit. Self-reported physical activity, location, vital sign and sleep stage information will be collected and monitored every day for up to eight (8) weeks. Data will be synced to the My Wellness Research Software Platform, resulting in a weekly text or phone call check-in, based on participants preference. Participants will receive a lifestyle medicine prescription pad, developed by the investigators, which serves as a checklist to assist participants in effectively monitoring their dietary habits and physical activity routines. Participants will also receive an 8-week text messages program which will direct participants to a webpage with nutrition and physical activity content. |
|
Sperimentale: Moderate Complexity Group
Participants in this group will receive the moderate complexity intervention for up to eight (8) weeks. |
Participants will be provided with a Fitbit. Self-reported physical activity, location, vital sign and sleep stage information will be collected and monitored every day for up to eight (8) weeks. Data will be synced to the My Wellness Research Software Platform, resulting in a weekly text or phone call check-in, based on participants preference. Participants will receive a lifestyle medicine prescription pad, developed by the investigators, which serves as a checklist to assist participants in effectively monitoring their dietary habits and physical activity routines. Participants will also receive an 8-week text messages program which will direct participants to a webpage with nutrition and physical activity content. The nutrition course will follow a combined asynchronous and synchronous approach. The asynchronous component will consist of a pre-recorded session covering educational nutrition content, which will be made available to participants for self-paced learning. This will be followed by a synchronous, 30-60 minute live group education class on nutrition information for cancer survivors, held once per week. The Physical Activity Program will be held virtually or in-person. This will be a 1-hour biweekly group education class on aerobic and resistance exercise recommendations for cancer survivors. |
|
Sperimentale: High Complexity Group
Participants in this group will receive the high complexity intervention for up to eight (8) weeks. |
Participants will be provided with a Fitbit. Self-reported physical activity, location, vital sign and sleep stage information will be collected and monitored every day for up to eight (8) weeks. Data will be synced to the My Wellness Research Software Platform, resulting in a weekly text or phone call check-in, based on participants preference. Participants will receive a lifestyle medicine prescription pad, developed by the investigators, which serves as a checklist to assist participants in effectively monitoring their dietary habits and physical activity routines. Participants will also receive an 8-week text messages program which will direct participants to a webpage with nutrition and physical activity content. Participants will be referred to weekly one on one nutrition counseling sessions with a Registered Dietitian. The one on one sessions are anticipated to last 30-60 minutes, based on the needs of the individual. Participants will be referred to weekly one on one exercise training sessions with an Exercise Physiologist. The one on one sessions are anticipated to last 30-60 minutes, based on the needs of the individual |
|
Nessun intervento: Control Group
Participants randomized to this arm will receive routine care and will not receive any study materials until the end of the study at 18 weeks. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Percentage of Survivors Who Agree to Participate
Lasso di tempo: Up to 8 Weeks
|
Percentage of survivors who agree to participate will be reported as ≥ 50%. |
Up to 8 Weeks
|
|
Percentage of Interventions Sessions Completed
Lasso di tempo: Up to 8 Weeks
|
Percentage of intervention sessions completed will be reported as ≥ 80%. |
Up to 8 Weeks
|
|
Percentage of Participants Satisfied with the Intervention
Lasso di tempo: Up to 8 Weeks
|
Report of 80% satisfaction will be determined as satisfaction with intervention components. |
Up to 8 Weeks
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Tracy Crane, PhD, RDN, University of Miami
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
- Malattie urogenitali
- Malattie genitali
- Neoplasie genitali, maschio
- Neoplasie urogenitali
- Neoplasie per sede
- Neoplasie
- Malattie genitali, maschio
- Malattie della prostata
- Malattie urogenitali maschili
- Malattie intestinali
- Malattie del sistema immunitario
- Neoplasie per tipo istologico
- Neoplasie gastrointestinali
- Neoplasie dell'apparato digerente
- Malattie dell'apparato digerente
- Malattie gastrointestinali
- Neoplasie intestinali
- Malattie del retto
- Malattie del colon
- Malattie della pelle
- Malattie del seno
- Malattie linfatiche
- Malattie linfoproliferative
- Disturbi immunoproliferativi
- Malattie della pelle e del tessuto connettivo
- Malattie emiche e linfatiche
- Neoplasie prostatiche
- Neoplasie colorettali
- Neoplasie mammarie
- Linfoma
- Dieta, cibo e nutrizione
- Fenomeni fisiologici
- Fenomeni fisiologici nutrizionali
- Caratteristiche della popolazione
- Stato di salute
- Demografia
- Stato nutrizionale
Altri numeri di identificazione dello studio
- 20230533
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .